Taryn Rogalski-Salter
HEAD OF GLOBAL REGULATORY STRATEGY at BILL & MELINDA GATES MEDICAL RESEARCH · MA · Healthcare
$540K
Peak Total Compensation
5
Years Tracked
7x
vs. Median Household
Taryn Rogalski-Salter has appeared in compensation disclosures over 5 years of available data (2019–2023). Total compensation changed from $536,518 to $399,661 - a -25.5% change.
Peak total compensation of $540,326 equals 7x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2023 | BILL & MELINDA GATES MEDICAL RESEARCH | HEAD OF GLOBAL REGULATORY STRATEGY | $351,238 | $48,423 | $399,661 |
| 2022 | BILL & MELINDA GATES MEDICAL RESEARCH | HEAD OF GLOBAL REG STRAT(END 1/3/22) | $465,694 | $74,632 | $540,326 |
| 2021 | BILL & MELINDA GATES MEDICAL RESEARCH | HEAD OF GLOBAL REG STRAT (START 5/2021) | $443,020 | $72,328 | $515,348 |
| 2020 | BILL & MELINDA GATES MEDICAL RESEARCH | HEAD OF GLOBAL REG STRATEGY | $436,655 | $70,479 | $507,134 |
| 2019 | BILL & MELINDA GATES MEDICAL RESEARCH | HEAD OF REGULATORY AFFAIRS | $468,311 | $68,207 | $536,518 |
Peers at BILL & MELINDA GATES MEDICAL RESEARCH
| Name | Title | Peak Comp. |
|---|---|---|
| Susan Desmond-Hellmann | DIRECTOR | $1.5M |
| Trevor Mundel | DIRECTOR, BOARD CHAIR | $1.5M |
| Carolyn Ainslie | DIRECTOR | $1.1M |
| David Kaufman | HEAD OF TRANSLATIONAL DEVELOPMENT | $997K |
| Michael Dunne | CHIEF MEDICAL OFFICER (END 12/24) | $910K |
| Emilio Emini | CHIEF EXECUTIVE OFFICER (END 6/24) | $900K |
| Penny Heaton | CEO (END 7/2021) | $875K |
| Helene Madonick | DIRECTOR (END 12/24) | $868K |
| Carolyn Ainslie Start 432020 | DIRECTOR | $843K |
| Harish Kaushal | TREASURER | $807K |
Email Alerts
Get notified about Taryn Rogalski-Salter
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →